Zai Lab (ZLAB) Research & Development (2018 - 2026)
Zai Lab (ZLAB) posted quarterly Research & Development of $65.6 million for Q1 2026, up 8.01% year-on-year from $60.7 million in Q1 2025, and up 6.42% on a QoQ basis from $61.6 million in Q4 2025.
Zai Lab (ZLAB) Research & Development (2018 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported Research & Development for 9 consecutive years, with $65.6 million the latest figure, recorded in Q1 2026.
- Quarterly Research & Development rose 8.01% year-over-year to $65.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $225.8 million (down 6.16% YoY) and the FY2025 annual result came in at $220.9 million, down 5.8% from the prior year.
- Research & Development rose to $65.6 million in Q1 2026 per ZLAB's latest filing, from $61.6 million in the prior quarter.
- Over the last five years, Research & Development for ZLAB reached as high as $99.5 million in Q3 2022 and fell as low as $47.9 million in Q3 2025.
- A 5-year average of $63.1 million and a median of $61.6 million in 2024 frame the typical range for Research & Development.
- The largest YoY upside for Research & Development was 80.48% in 2022 against a maximum downside of 73.58% in 2022.
- Year by year, Research & Development stood at $66.9 million in 2022, then grew by 22.41% to $81.9 million in 2023, then slumped by 36.24% to $52.3 million in 2024, then grew by 17.95% to $61.6 million in 2025, then increased by 6.42% to $65.6 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $65.6 million, $61.6 million, and $47.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn | 65.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.59 Mn |
| Dec 31, 2025 | 61.63 Mn |
| Sep 30, 2025 | 47.93 Mn |
| Jun 30, 2025 | 50.61 Mn |
| Mar 31, 2025 | 60.73 Mn |
| Dec 31, 2024 | 52.25 Mn |
| Sep 30, 2024 | 65.98 Mn |
| Jun 30, 2024 | 61.63 Mn |
| Mar 31, 2024 | 54.65 Mn |
| Dec 31, 2023 | 81.95 Mn |
| Sep 30, 2023 | 58.77 Mn |
| Jun 30, 2023 | 76.68 Mn |
| Mar 31, 2023 | 48.47 Mn |
| Dec 31, 2022 | 66.95 Mn |
| Sep 30, 2022 | 99.52 Mn |
| Jun 30, 2022 | 66.08 Mn |
| Mar 31, 2022 | 53.85 Mn |
| Dec 31, 2021 | 172.09 Mn |
| Sep 30, 2021 | 55.14 Mn |
| Jun 30, 2021 | 142.22 Mn |